ロード中...
CD8(+) PD-1(+) T-cells and PD-L1(+) circulating tumor cells in chemotherapy-naïve non-small cell lung cancer: towards their clinical relevance?
BACKGROUND: Since tumor cells may escape from immune surveillance through the programmed cell death 1 (PD-1)/programmed death ligand (PD-L)1 axis, this study was designed in order to evaluate whether there is a correlation between the levels of PD-1(+) and PD-L1(+)-expressing immune cells (ICs) and...
保存先:
| 出版年: | Ther Adv Med Oncol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6563396/ https://ncbi.nlm.nih.gov/pubmed/31217824 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835919853193 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|